Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors
Myeloid Therapeutics
Myeloid Therapeutics
Nurix Therapeutics, Inc.
Guardant Health, Inc.
858 Therapeutics, Inc.
Medicenna Therapeutics, Inc.
Stanford University